FATE Fate Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,32
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,9552-Wochen-Tief
$3,2352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$271M
P/E (TTM)
-2.2
EPS (TTM)
$-1.05
Umsatz (TTM)
$6M
Ihre Abzeichen
52W-Spanne
$1–$3
Analystenbewertung
HOLD
Kursziel
$6
P/E
-2.2
ROE
-60.7%
Nettogewinnmarge
-1941.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
FATE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.32
Marktkapitalisierung (MRQ)
$271M
P/E (TTM)
-2.2
EPS (TTM)
$-1.05
Umsatz (TTM)
$6M
ROE (TTM)
-60.7%
52W-Spanne
$1–$3
FATE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Fate Therapeutics, Inc. - Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter161
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$7M2016-12-31 → 2025-12-31
EPS$-1.152020-12-31 → 2025-12-31
Freier Cashflow$-112M2016-12-31 → 2025-12-31
Nettogewinnmarge-1941.1%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FATE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.25-Jahres-Durchschnitt ≈-6.7 | ≈-6.7 | · | · | |
| P/S (TTM) | 41.75-Jahres-Durchschnitt ≈29.4 | ≈29.4 | 48.5 | Fairer Wert | |
| K/B (MRQ) | 1.85-Jahres-Durchschnitt ≈2.5 | ≈2.5 | 1.7 | Überbewertet | |
| Kurs / FCF (TTM) | -2.65-Jahres-Durchschnitt ≈-7.0 | ≈-7.0 | · | · | |
| Kurs / Cashflow (TTM) | -2.75-Jahres-Durchschnitt ≈-8.7 | ≈-8.7 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 1.35-Jahres-Durchschnitt ≈2.5 | ≈2.5 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FATE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -2058.1%5-Jahres-Durchschnitt ≈-954.7% | ≈-954.7% | -623.6% | Schwach | |
| EBITDA-Marge (TTM) | -1873.4%5-Jahres-Durchschnitt ≈-877.4% | ≈-877.4% | -619.0% | Schwach | |
| Nettogewinnmarge (TTM) | -1941.1%5-Jahres-Durchschnitt ≈-868.7% | ≈-868.7% | -529.8% | Schwach | |
| ROA (TTM) | -39.9%5-Jahres-Durchschnitt ≈-32.8% | ≈-32.8% | -35.2% | Im Einklang | |
| ROE (TTM) | -60.7%5-Jahres-Durchschnitt ≈-48.2% | ≈-48.2% | -45.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FATE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 4.85-Jahres-Durchschnitt ≈6.8 | ≈6.8 | 8.3 | Geringe Liquidität | |
| Quick Ratio (MRQ) | 4.75-Jahres-Durchschnitt ≈5.4 | ≈5.4 | 6.3 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FATE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -51.2%5-Jahres-Durchschnitt ≈-2.7% | ≈-2.7% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -59.0%5-Jahres-Durchschnitt ≈-23.4% | ≈-23.4% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -26.7% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FATE | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.0 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 3.05-Jahres-Durchschnitt ≈4.6 | ≈4.6 | 3.6 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$41.3K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
10.6%
Nächster Bericht
Nov 11, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 13, 2026 | $-0.25 | $-0.27 | 8.5% |
| 31. März 2026 | Mai 11, 2026 | $-0.26 | $-0.29 | 9.0% |
| 31. Dezember 2025 | $-0.27 | $-0.28 | 1.9% | |
| 30. September 2025 | $-0.27 | $-0.30 | 9.1% | |
| 30. Juni 2025 | $-0.29 | $-0.35 | 17.0% | |
| 31. März 2025 | $-0.32 | $-0.39 | 18.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | · | |
| R&D Expense | $108M | $135M | $173M | $320M | $216M | $126M | $88M | $56M | $34M | $26M | $20M | $16M | |
| SG&A Expense | $47M | $74M | $81M | $84M | $57M | $34M | $24M | $16M | $12M | $10M | $10M | $8M | |
| Operating Expenses | $154M | $224M | $254M | $405M | $273M | $160M | $111M | $72M | $46M | $36M | $30M | $25M | |
| Operating Income | $-148M | $-210M | $-191M | $-308M | $-217M | $-128M | $-101M | $-67M | $-42M | $-32M | $-28M | $-25M | |
| Interest Expense | · | · | · | · | $0 | $0 | $2M | $2M | $1M | $2M | $2M | $549.0K | |
| Interest Income | $11M | $17M | $17M | $6M | $1M | $2M | $4M | $2M | $559.0K | $138.0K | $10.0K | $2.0K | |
| Other Non-op | $11M | $24M | $30M | $27M | $5M | $-45M | $3M | $494.0K | $-827.0K | $-1M | $-2M | $-979.0K | |
| Income Tax | $2.0K | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| EPS (Basic) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| EPS (Diluted) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · | |
| Shares (Basic) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| Shares (Diluted) | 118,789,974 | 113,685,177 | 98,411,162 | 96,826,058 | 94,747,311 | 82,385,319 | · | · | · | · | · | · | |
| EBITDA | $-135M | $-191M | $-172M | $-295M | $-211M | $-125M | $-99M | $-66M | $-41M | $-31M | $-27M | $-24M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $47M | $36M | $42M | $61M | $134M | $167M | $100M | $191M | $89M | $89M | $65M | $49M | |
| Short-term Investments | $157M | $243M | $273M | $375M | $482M | · | · | · | · | $4M | · | · | |
| Receivables | $916.0K | $4M | $2M | $38M | $9M | $6M | · | $500.0K | · | · | · | · | |
| Prepaid Expense | $4M | $9M | $15M | $27M | $9M | $6M | $6M | $4M | $2M | $1M | $843.0K | $760.0K | |
| Current Assets | $209M | $292M | $332M | $502M | $633M | $494M | $227M | $205M | $103M | $93M | $66M | $50M | |
| PP&E (Net) | $57M | $64M | $97M | $110M | $92M | $32M | $11M | $5M | $3M | $2M | $2M | $1M | |
| PP&E (Gross) | $93M | $100M | $144M | $140M | $108M | $43M | $20M | $11M | $8M | $6M | $6M | $4M | |
| Accum. Depreciation | $36M | $35M | $48M | $30M | $17M | $11M | $9M | $6M | $5M | $4M | $3M | $3M | |
| Other Non-current Assets | $0 | $9.0K | $9.0K | $33.0K | $33.0K | $9.0K | $9.0K | $526.0K | $24.0K | $24.0K | $24.0K | $10.0K | |
| Total Assets | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Accounts Payable | $3M | $9M | $5M | $8M | $9M | $6M | $6M | $4M | $2M | $934.0K | $996.0K | $645.0K | |
| Accrued Liabilities | $20M | $21M | $28M | $54M | $42M | $16M | $15M | $11M | $7M | $4M | $2M | $2M | |
| Current Liabilities | $36M | $39M | $39M | $114M | $81M | $86M | $28M | $27M | $11M | $15M | $13M | $5M | |
| Capital Leases | $73M | $78M | $97M | $104M | $109M | $94M | $25M | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $18M | $19M | $13M | $22M | $20M | |
| Total Debt | · | · | · | · | · | · | · | $15M | $15M | $11M | $18M | $20M | |
| Common Stock | $115.0K | $114.0K | $99.0K | $97.0K | $96.0K | $88.0K | $76.0K | $65.0K | $53.0K | $41.0K | $29.0K | $21.0K | |
| Paid-in Capital | $1.74B | $1.72B | $1.58B | $1.54B | $1.45B | $941M | $628M | $446M | $296M | $249M | · | $141M | |
| Retained Earnings | $-1.53B | $-1.40B | $-1.21B | $-1.05B | $-769M | $-557M | $-384M | $-285M | $-219M | $-176M | $-142M | $-112M | |
| AOCI | $116.0K | $268.0K | $15.0K | $-2M | $-762.0K | $70.0K | $22.0K | $-2.0K | $-3.0K | $-1.0K | · | · | |
| Stockholders' Equity | $207M | $319M | $368M | $484M | $679M | $384M | $245M | $160M | $77M | $73M | $38M | $28M | |
| Liabilities + Equity | $319M | $441M | $506M | $706M | $921M | $622M | $302M | $213M | $105M | $95M | $68M | $51M | |
| Shares Outstanding | 115,359,735 | 113,928,279 | 98,627,076 | 97,294,917 | 95,726,962 | 87,722,237 | 75,730,260 | 64,693,681 | 52,648,601 | 41,386,506 | 28,716,570 | 20,569,399 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13M | $19M | $18M | $14M | $6M | $3M | $2M | $1M | $971.0K | $881.0K | $687.0K | $496.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | $2M | $2M | |
| Restructuring | $1M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $17M | $44M | $10M | $20M | $43M | $131M | $13M | $27M | $5M | $3M | $9M | $534.0K | |
| Operating Cash Flow | $-106M | $-123M | $-132M | $-248M | $-163M | $-39M | $-83M | $-39M | $-37M | $-30M | $-18M | $-22M | |
| CapEx | $6M | $730.0K | $6M | $36M | $51M | $5M | $7M | $2M | $2M | $457.0K | $1M | $882.0K | |
| Investing Cash Flow | $111M | $12M | $113M | $167M | $-324M | $-161M | $-157M | $-463.0K | $-10M | $-4M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $15M | · | · | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $-15M | · | $4M | $-8M | $-2M | $18M | |
| Stock Issued | · | · | · | · | $412M | $189M | $162M | $135M | $43M | · | $5M | $142.0K | |
| Net Stock Activity | · | · | · | · | $412M | $189M | $162M | · | · | · | $5M | $142.0K | |
| Financing Cash Flow | $5M | $100M | $85.0K | $9M | $453M | $283M | $150M | $141M | $47M | $58M | · | · | |
| Net Change in Cash | $11M | $-11M | $-20M | $-72M | $-34M | $83M | $-91M | $102M | $343.0K | $24M | $16M | $-5M | |
| Taxes Paid | $1.6K | $1.7K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-112M | $-124M | $-138M | $-284M | $-214M | $-44M | $-91M | $-41M | $-39M | $-30M | $-20M | $-23M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% | -943.1% | -1415.4% | · | · | -1142.8% | · | |
| Net Margin | -2051.1% | -1366.5% | -253.3% | -292.6% | -379.9% | -551.6% | -919.0% | -1405.0% | · | · | -1233.7% | · | |
| EBITDA Margin | -2028.3% | -1403.5% | -271.1% | -305.9% | -378.1% | -397.7% | -922.6% | -1390.0% | · | · | -1114.6% | · | |
| ROA | -35.9% | -39.3% | -26.6% | -34.6% | -27.5% | -37.5% | -38.1% | -41.8% | -42.9% | -41.1% | -50.3% | -48.5% | |
| ROE | -58.2% | -54.7% | -41.7% | -56.2% | -30.1% | -42.9% | -38.3% | -39.8% | -69.9% | -60.2% | -90.4% | -65.4% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 | 5.8 | 8.2 | 7.5 | 9.3 | 6.1 | 4.9 | 10.9 | |
| Quick Ratio | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 | 2.0 | 3.6 | 7.0 | 8.1 | 6.1 | 4.8 | 10.7 | |
| Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.1 | 0.5 | 0.7 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.1 | 0.2 | 0.0 | 0.3 | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | -57.5 | -39.6 | -33.2 | -19.5 | -12.5 | -45.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | · | · | 0.0 | · | |
| Receivables Turnover | 3.0 | 5.1 | 3.2 | 4.1 | 7.9 | 10.5 | · | 19.0 | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.80 | $2.80 | $3.74 | $4.97 | $7.09 | $4.38 | $3.23 | $2.48 | $1.47 | $1.77 | $1.32 | $1.38 | |
| Revenue / Share | $0.06 | $0.12 | $0.65 | $0.99 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.89 | $-1.08 | $-1.34 | $-2.56 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.40 | $0.32 | $0.42 | $0.63 | $1.40 | $1.91 | $1.32 | $2.94 | $1.69 | $2.14 | $2.26 | $2.39 | |
| EPS (TTM) | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 | $-2.10 | · | · | · | · | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -51.2% | -78.5% | -34.0% | 72.4% | 77.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -59.0% | -37.5% | 26.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -26.7% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $14M | $64M | $96M | $56M | $31M | $11M | $5M | $4M | $4M | $2M | $2M | |
| Net Income TTM | $-136M | $-186M | $-161M | $-282M | $-212M | $-173M | $-98M | $-67M | $-43M | $-33M | $-30M | $-26M | |
| Market Cap | $113M | $188M | $369M | $982M | $5.60B | $7.98B | $1.48B | $830M | $322M | $104M | $97M | $103M | |
| Enterprise Value | · | · | · | · | · | · | · | $654M | $248M | $22M | $50M | $74M | |
| P/E | -0.9 | -1.0 | -2.3 | -3.5 | -26.1 | -43.3 | · | · | · | · | · | · | |
| P/S | 17.0 | 13.8 | 5.8 | 10.2 | 100.3 | 253.8 | 138.8 | 175.1 | 78.3 | 23.6 | 39.8 | 64.1 | |
| P/B | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | 6.1 | 5.2 | 4.2 | 1.4 | 2.5 | 3.7 | |
| P / Tangible Book | 0.5 | 0.6 | 1.0 | 2.0 | 8.3 | 20.7 | · | · | · | · | · | · | |
| P / Cash Flow | -1.1 | -1.5 | -2.8 | -4.0 | -34.4 | -203.3 | -17.8 | -21.5 | -8.7 | -3.5 | -5.3 | -4.6 | |
| P / FCF | -1.0 | -1.5 | -2.7 | -3.5 | -26.2 | -180.6 | -16.4 | -20.3 | -8.3 | -3.4 | -4.9 | -4.4 | |
| EV / EBITDA | · | · | · | · | · | · | · | -9.9 | -6.0 | -0.7 | -1.9 | -3.0 | |
| EV / FCF | · | · | · | · | · | · | · | -16.0 | -6.4 | -0.7 | -2.5 | -3.2 | |
| EV / Revenue | · | · | · | · | · | · | · | 138.1 | 60.3 | 5.1 | 20.7 | 45.8 | |
| Earnings Yield | -117.3% | -99.4% | -43.9% | -28.8% | -3.8% | -2.3% | · | · | · | · | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $7M | $2M | $2M | $2M | $933.0K | $59M | $44M | $15M | |
| R&D Expense | $24M | $25M | $25M | $26M | $27M | $29M | $34M | $35M | $35M | $32M | $32M | $34M | $41M | $66M | $87M | $80M | |
| SG&A Expense | $9M | $10M | $11M | $11M | $11M | $14M | $15M | $21M | $17M | $21M | $18M | $19M | $23M | $22M | $22M | $22M | |
| Operating Expenses | $33M | $34M | $36M | $36M | $39M | $43M | $64M | $55M | $52M | $53M | $50M | $53M | $63M | $88M | $109M | $101M | |
| Operating Income | $-31M | $-33M | $-35M | $-35M | $-37M | $-41M | $-62M | $-52M | $-45M | $-51M | $-48M | $-51M | $-63M | $-29M | $-64M | $-86M | |
| Interest Income | $2M | $2M | $2M | $3M | $3M | $3M | $4M | $4M | $5M | $4M | $4M | $5M | $4M | $4M | $3M | $2M | |
| Other Non-op | $975.0K | $2M | $2M | $2M | $3M | $4M | $10M | $5M | $7M | $3M | $4M | $6M | $10M | $10M | $8M | $3M | |
| Net Income | $-30M | $-31M | $-32M | $-32M | $-34M | $-38M | $-52M | $-48M | $-38M | $-48M | $-44M | $-45M | $-53M | $-19M | $-56M | $-84M | |
| EPS (Basic) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| EPS (Diluted) | $-0.25 | $-0.26 | $-0.27 | $-0.27 | $-0.29 | $-0.32 | $-0.44 | $-0.40 | $-0.33 | $-0.47 | $-0.45 | $-0.46 | $-0.54 | $-0.19 | $-0.58 | $-0.86 | |
| Shares (Basic) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| Shares (Diluted) | 120,397,390 | 120,030,638 | · | 118,998,693 | 118,528,046 | 118,375,540 | · | 117,769,161 | 117,468,124 | 101,104,345 | · | 98,568,012 | 98,400,355 | 98,054,687 | · | 97,023,506 | |
| EBITDA | $-31M | $-30M | · | $-35M | $-37M | $-38M | · | $-52M | $-45M | $-46M | · | $-51M | $-63M | $-24M | · | $-86M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $40M | $47M | $41M | $41M | $45M | $36M | $38M | $37M | $121M | $42M | $33M | $47M | $42M | $61M | $82M | |
| Short-term Investments | $121M | $135M | $157M | $175M | $182M | $196M | $243M | $259M | $268M | · | $273M | · | · | · | $375M | · | |
| Receivables | $703.0K | $704.0K | $916.0K | $682.0K | $1M | $2M | $4M | $4M | $1M | $858.0K | $2M | $2M | $3M | $14M | $38M | $10M | |
| Prepaid Expense | $3M | $4M | $4M | $5M | $6M | $5M | $9M | $9M | $13M | $10M | $15M | $13M | $11M | $15M | $27M | $20M | |
| Current Assets | $158M | $180M | $209M | $221M | $230M | $248M | $292M | $310M | $319M | $394M | $332M | $364M | $392M | $438M | $502M | $535M | |
| PP&E (Net) | $52M | $54M | $57M | $59M | $61M | $63M | $64M | $82M | $88M | $92M | $97M | $102M | $106M | $109M | $110M | $109M | |
| PP&E (Gross) | · | · | $93M | · | · | · | $100M | · | · | · | $144M | · | · | · | $140M | · | |
| Accum. Depreciation | · | · | $36M | · | · | · | $35M | · | · | · | $48M | · | · | · | $30M | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $0 | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $33.0K | $33.0K | $33.0K | $33.0K | |
| Total Assets | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Accounts Payable | $3M | $3M | $3M | $4M | $4M | $4M | $9M | $6M | $5M | $7M | $5M | $6M | $8M | $10M | $8M | $10M | |
| Accrued Liabilities | $15M | $14M | $20M | $18M | $18M | $17M | $21M | $24M | $23M | $32M | $28M | $29M | $29M | $32M | $54M | $50M | |
| Current Liabilities | $33M | $31M | $36M | $28M | $29M | $28M | $39M | $37M | $35M | $45M | $39M | $41M | $45M | $49M | $114M | $104M | |
| Capital Leases | $71M | $72M | $73M | $74M | $76M | $77M | $78M | $92M | $94M | $96M | $97M | $99M | $101M | $102M | $104M | $105M | |
| Common Stock | $117.0K | $116.0K | $115.0K | $115.0K | $115.0K | $115.0K | $114.0K | $114.0K | $114.0K | $114.0K | $99.0K | $99.0K | $99.0K | $98.0K | $97.0K | $97.0K | |
| Paid-in Capital | $1.75B | $1.75B | $1.74B | $1.74B | $1.73B | $1.72B | $1.72B | $1.71B | $1.70B | $1.69B | $1.58B | $1.57B | $1.56B | $1.55B | $1.54B | $1.52B | |
| Retained Earnings | $-1.60B | $-1.57B | $-1.53B | $-1.50B | $-1.47B | $-1.44B | $-1.40B | $-1.35B | $-1.30B | $-1.26B | $-1.21B | $-1.17B | $-1.12B | $-1.07B | $-1.05B | $-994M | |
| AOCI | $-117.0K | $-77.0K | $116.0K | $153.0K | $62.0K | $191.0K | $268.0K | $835.0K | $-422.0K | $-194.0K | $15.0K | $-499.0K | $-587.0K | $-646.0K | $-2M | $-3M | |
| Stockholders' Equity | $153M | $180M | $207M | $234M | $261M | $288M | $319M | $362M | $397M | $426M | $368M | $403M | $438M | $477M | $484M | $518M | |
| Liabilities + Equity | $260M | $285M | $319M | $344M | $372M | $399M | $441M | $495M | $529M | $570M | $506M | $544M | $585M | $630M | $706M | $749M | |
| Shares Outstanding | 116,694,106 | 116,272,513 | 115,359,735 | 115,336,697 | 114,655,067 | 114,603,910 | 113,928,279 | 113,884,884 | 113,849,557 | 113,798,942 | 98,627,076 | 98,585,750 | 98,522,718 | 98,191,015 | 97,294,917 | 97,112,209 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $3M | |
| Restructuring | · | · | · | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $-3M | · | · | · | $479.0K | · | · | · | $10M | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $-23M | $-31M | $-23M | $-24M | $-25M | $-34M | $-28M | $-29M | $-32M | $-33M | $-37M | $-38M | $-28M | $-29M | $-75M | $-55M | |
| CapEx | $80.0K | $239.0K | $1M | $2M | $1M | $1M | $98.0K | $495.0K | $51.0K | $86.0K | $181.0K | $565.0K | $2M | $3M | $7M | $9M | |
| Investing Cash Flow | $15M | $24M | $28M | $21M | $20M | $43M | $23M | $25M | $-53M | $17M | $45M | $25M | $33M | $9M | $53M | $80M | |
| Stock Issued | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $-104.0K | $75M | · | · | · | · | · | · | |
| Financing Cash Flow | · | · | $2M | $2M | $1M | $0 | $3M | $0 | $1M | $95M | $-180.0K | $0 | $58.0K | $207.0K | $2M | $1M | |
| Net Change in Cash | $-7M | $-7M | $6M | $-627.0K | $-4M | $9M | $-2M | $-4M | $-84M | $79M | $9M | $-13M | $5M | $-19M | $-21M | $27M | |
| Free Cash Flow | · | $-31M | · | · | · | $-35M | · | · | · | $-33M | · | · | · | $-32M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1495.4% | -2540.4% | · | -1995.1% | -1938.5% | -2534.1% | · | -1703.9% | -665.7% | -2652.9% | · | -2637.8% | -6705.8% | -48.5% | · | -576.7% | |
| Net Margin | -1448.6% | -2402.8% | · | -1852.4% | -1786.6% | -2309.4% | · | -1551.0% | -567.4% | -2493.7% | · | -2323.6% | -5654.3% | -32.0% | · | -557.8% | |
| EBITDA Margin | -1495.4% | -2315.8% | · | -1995.1% | -1938.5% | -2329.5% | · | -1703.9% | -665.7% | -2402.4% | · | -2637.8% | -6705.8% | -41.4% | · | -576.7% | |
| ROA | -9.6% | -9.1% | · | -7.7% | -7.6% | -7.8% | · | -9.2% | -6.9% | -8.0% | · | -7.0% | -7.6% | -2.5% | · | -9.6% | |
| ROE | -14.5% | -13.3% | · | -10.8% | -10.3% | -10.5% | · | -12.5% | -9.2% | -10.6% | · | -9.8% | -10.4% | -3.4% | · | -13.4% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.8 | 5.8 | · | 7.9 | 8.0 | 8.8 | · | 8.3 | 9.2 | 8.7 | · | 8.8 | 8.8 | 9.0 | · | 5.2 | |
| Quick Ratio | 4.7 | 5.7 | · | 7.7 | 7.8 | 8.6 | · | 8.0 | 8.8 | 2.7 | · | 0.8 | 1.1 | 1.1 | · | 0.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| Receivables Turnover | 2.0 | 0.8 | · | 0.7 | 1.6 | 1.0 | · | 1.1 | 3.5 | 0.3 | · | 0.3 | 0.1 | 4.3 | · | 1.7 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.31 | $1.55 | · | $2.03 | $2.28 | $2.52 | · | $3.18 | $3.49 | $3.74 | · | $4.09 | $4.44 | $4.86 | · | $5.33 | |
| Revenue / Share | $0.02 | $0.01 | · | $0.01 | $0.02 | $0.01 | · | $0.03 | $0.06 | $0.02 | · | $0.02 | $0.01 | $0.60 | · | $0.15 | |
| Cash Flow / Share | $-0.19 | $-0.26 | · | · | · | $-0.29 | · | · | · | $-0.33 | · | · | · | $-0.29 | · | · | |
| Cash / Share | $0.28 | $0.34 | · | $0.35 | $0.36 | $0.39 | · | $0.33 | $0.32 | $1.07 | · | $0.34 | $0.47 | $0.43 | · | $0.85 | |
| EPS (TTM) | $-1.05 | $-1.09 | · | $-1.32 | $-1.45 | $-1.49 | · | $-1.65 | $-1.71 | $-1.92 | · | $-1.77 | $-2.17 | $-2.42 | · | $-3.05 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $6M | · | $7M | $8M | $13M | · | $13M | $12M | $6M | · | $106M | $119M | $137M | · | $69M | |
| Net Income TTM | $-126M | $-130M | · | $-156M | $-172M | $-176M | · | $-178M | $-176M | $-190M | · | $-173M | $-212M | $-235M | · | $-294M | |
| Market Cap | $315M | $140M | · | $145M | $128M | $91M | · | $399M | $373M | $835M | · | $209M | $469M | $560M | · | $2.18B | |
| P/E | -2.6 | -1.1 | · | -1.0 | -0.8 | -0.5 | · | -2.1 | -1.9 | -3.8 | · | -1.2 | -2.2 | -2.4 | · | -7.3 | |
| P/S | 48.5 | 22.1 | · | 20.4 | 15.2 | 6.8 | · | 29.6 | 30.3 | 128.9 | · | 2.0 | 3.9 | 4.1 | · | 31.5 | |
| P/B | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Tangible Book | 2.1 | 0.8 | · | 0.6 | 0.5 | 0.3 | · | 1.1 | 0.9 | 2.0 | · | 0.5 | 1.1 | 1.2 | · | 4.2 | |
| P / Cash Flow | -13.5 | -4.5 | · | · | · | -2.7 | · | · | · | -25.0 | · | · | · | -19.4 | · | · | |
| Earnings Yield | -38.9% | -90.8% | · | -104.8% | -129.5% | -188.6% | · | -47.1% | -52.1% | -26.2% | · | -83.5% | -45.6% | -42.5% | · | -13.6% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $7M | $14M | $64M | $96M | $56M |
| Betriebsgewinnmarge % | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% |
| Nettoergebnis | $-136M | $-186M | $-161M | $-282M | $-212M |
| Verwässerte EPS | $-1.15 | $-1.64 | $-1.64 | $-2.91 | $-2.24 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 5.8 | 7.6 | 8.5 | 4.4 | 7.8 |
| Quick Ratio | 5.7 | 7.3 | 8.1 | 4.2 | 1.8 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-112M | $-124M | $-138M | $-284M | $-214M |
Institutionelle Eigentümer (13F) 166 Einreicher · $189.3M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
166
Gehaltener Wert
$189.3M
Neue Positionen
33
Geschlossene Positionen
30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 33 (+2 vs. Vorquartal) | 30 (+16 vs. Vorquartal) | 60 (+5 vs. Vorquartal) | 36 (+2 vs. Vorquartal) | -1.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Redmile Group, LLC | $34.756.954 | 12.872.946 | 18,36% | Aktien |
| BlackRock, Inc. | $19.707.016 | 7.298.895 | 10,41% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12.273.911 | 4.545.893 | 6,48% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.002.947 | 4.445.536 | 6,34% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $10.360.518 | 3.837.229 | 5,47% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $9.692.630 | 3.589.863 | 5,12% | Aktien |
| JOHNSON & JOHNSON | $9.123.473 | 3.379.064 | 4,82% | Aktien |
| VANGUARD GROUP INC | $8.818.834 | 8.971.347 | 4,66% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $8.054.824 | 2.983.268 | 4,25% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $6.571.741 | 2.433.978 | 3,47% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.532.805 | 2.049.187 | 2,92% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.571.058 | 1.322.013 | 1,89% | Aktien |
| JANE STREET GROUP, LLC | $2.772.919 | 1.027.007 | 1,46% | Aktien |
| CITADEL ADVISORS LLC | $2.681.931 | 993.308 | 1,42% | Aktien |
| Bruce & Co., Inc. | $2.670.808 | 989.188 | 1,41% | Aktien |
| MORGAN STANLEY | $1.875.366 | 694.580 | 0,99% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.729.156 | 640.428 | 0,91% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.649.562 | 610.949 | 0,87% | Aktien |
| TWO SIGMA ADVISERS, LP | $1.622.960 | 1.651.700 | 0,86% | Aktien |
| UBS Group AG | $1.593.481 | 590.178 | 0,84% | Aktien |
| Qube Research & Technologies Ltd | $1.561.005 | 578.150 | 0,82% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.552.487 | 574.995 | 0,82% | Aktien |
| STATE STREET CORP | $1.509.106 | 558.928 | 0,80% | Aktien |
| DAFNA Capital Management LLC | $1.417.500 | 525.000 | 0,75% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.379.835 | 511.050 | 0,73% | Aktien |
| MARSHALL WACE, LLP | $1.329.551 | 492.426 | 0,70% | Aktien |
| IEQ CAPITAL, LLC | $1.316.866 | 487.728 | 0,70% | Aktien |
| Point72 Asset Management, L.P. | $1.194.016 | 442.228 | 0,63% | Aktien |
| Privium Fund Management B.V. | $1.118.640 | 414.311 | 0,59% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $949.091 | 352.226 | 0,50% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $912.757 | 338.058 | 0,48% | Aktien |
| Cerity Partners LLC | $854.028 | 341.732 | 0,45% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $733.412 | 271.634 | 0,39% | Aktien |
| Invesco Ltd. | $718.151 | 265.982 | 0,38% | Aktien |
| Headlands Technologies LLC | $679.865 | 251.802 | 0,36% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $663.697 | 245.814 | 0,35% | Aktien |
| NORTHERN TRUST CORP | $655.212 | 242.671 | 0,35% | Aktien |
| HSBC HOLDINGS PLC | $635.511 | 240.724 | 0,34% | Aktien |
| LPL Financial LLC | $550.114 | 203.746 | 0,29% | Aktien |
| Mariner, LLC | $518.762 | 192.215 | 0,27% | Aktien |
| BARCLAYS PLC | $507.571 | 187.989 | 0,27% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $499.500 | 185.000 | 0,26% | Aktien |
| XTX Topco Ltd | $488.230 | 180.826 | 0,26% | Aktien |
| Aster Capital Management (DIFC) Ltd | $476.820 | 176.600 | 0,25% | Aktien |
| Man Group plc | $475.489 | 176.107 | 0,25% | Aktien |
| Woodline Partners LP | $431.055 | 159.650 | 0,23% | Aktien |
| BANK OF AMERICA CORP /DE/ | $415.006 | 153.706 | 0,22% | Aktien |
| Squarepoint Ops LLC | $414.785 | 153.624 | 0,22% | Aktien |
| Arete Wealth Advisors, LLC | $405.000 | 150.000 | 0,21% | Aktien |
| Assenagon Asset Management S.A. | $393.763 | 145.838 | 0,21% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, RedCo II Offshore SPV LLC, RedCo II Master Fund, L.P. ×11 Einreichungen | 22. April 2026 | 14,90% | Änderung | · | SEC |
| Polaris Venture Partners V, L.P. (“PVP V”), Polaris Venture Partners Entrepreneurs’ Fund V, L.P. (“PVPE V”), Polaris Venture Partners Founders’ Fund V, L.P. (“PVPFF V”), Polaris Venture Partners Special Founders’ Fund V, L.P. (“PVPSFF V”), Polaris Venture Management Co. V, L.L.C. (“PVM V”), Jonathan A. Flint (“Flint”), Terrance G. McGuire (“McGuire”), Amir Nashat (“Nashat”) ×2 Einreichungen | 21. Dezember 2018 | · | Erste Einreichung | · | SEC |
| 5. Dezember 2016 | · | Erste Einreichung | · | SEC | |
| ARCH Venture Fund VI, L.P., ARCH Venture Partners VI, L.P., ARCH Venture Partners VI, LLC, Clinton Bybee, Keith Crandell, Robert Nelsen ×3 Einreichungen | 15. August 2016 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 30 Insider · 13 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Scott J Wolchko | President and CEO | 1. Februar 2024 A | 371.248 | 0 | 0 | $0 |
| Christian Weyer | President and Chief Executive Officer | 13. April 2015 M | 30.429 | 0 | 0 | $0 |
| Kamal Adawi | Chief Financial Officer | 15. Januar 2026 A | 100.000 | 0 | 0 | $0 |
| Edward J Dulac III | Chief Financial Officer | 4. März 2024 S | 101.479 | 0 | 0 | $0 |
| Jerome Charles Bressi | Chief Regulatory and Quality Officer | 15. Januar 2025 A | 335.203 | 0 | 0 | $0 |
| Brian T. Powl | Chief Commercial Officer | 5. Juli 2023 S | 41.146 | 0 | 0 | $0 |
| Yu-Waye Chu | Chief Medical Officer | 18. April 2023 S | 140.676 | 0 | 0 | $0 |
| Mark Plavsic | Chief Technical Officer | 10. Januar 2023 S | 123.705 | 0 | 0 | $0 |
| Daniel D Shoemaker | Chief Scientific Officer | 8. März 2021 S | 73.020 | 0 | 0 | $0 |
| Stewart Abbot | Chief Development Officer | 15. Mai 2018 M | 64.917 | 0 | 0 | $0 |
| Chris Storgard | Chief Medical Officer | 16. Januar 2018 A | 37.593 | 0 | 0 | $0 |
| Peter D Flynn | Senior Vice President, Early Program Development | 5. Januar 2015 A | 6.505 | 0 | 0 | $0 |
| Pratik S Multani | Chief Medical Officer | 5. Januar 2015 A | 3.024 | 0 | 0 | $0 |
| Yuan Xu | Direktor | 12. Juni 2026 A | 8.669 | 0 | 0 | $0 |
| Karin Jooss | Direktor | 12. Juni 2026 A | 9.848 | 0 | 0 | $0 |
| Laura Hamill | Direktor | 12. Juni 2026 A | · | 0 | 0 | $0 |
| Michael Stewart Lee | Direktor | 12. Juni 2026 A | 11.331 | 0 | 0 | $0 |
| Shefali Agarwal | Direktor | 12. Juni 2026 A | 10.490 | 0 | 0 | $0 |
| Matt Abernethy | Direktor | 12. Juni 2026 A | · | 0 | 0 | $0 |
| Robert S Epstein | Direktor | 12. Juni 2026 A | 36.331 | 0 | 0 | $0 |
| William H Rastetter | Direktor | 12. Juni 2026 A | 36.331 | 0 | 0 | $0 |
| Neelufar Mozaffarian | Direktor | 29. Mai 2025 A | · | 0 | 0 | $0 |
| John Mendlein | Direktor | 29. Mai 2025 A | 311.231 | 0 | 0 | $0 |
| Timothy Coughlin | Direktor | 7. Juni 2024 A | 9.892 | 0 | 0 | $0 |
| Robert Hershberg | Direktor | 6. Juni 2023 A | 10.659 | 0 | 0 | $0 |
| Amir Nashat | Direktor | 1. August 2019 S | 11.034 | 0 | 0 | $0 |
| Mark J Enyedy | Direktor | 11. Mai 2016 A | · | 0 | 0 | $0 |
| Robert Nelsen | Direktor | 4. Oktober 2013 C | 2.473.188 | 0 | 0 | $0 |
| Bahram Valamehr | · | 4. August 2026 S | 591.815 | 0 | 3 | $-168.081 |
| Cindy Tahl | · | 4. August 2026 S | 589.355 | 0 | 3 | $-154.781 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 8 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,51% | 50.199 SH | 1. Oktober 2026 | Täglich |
| IWC · iShares Trust | 0,06% | 387.392 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 228.436 SH | 29. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,00% | 15.790 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 6.246 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.149.276 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.194.411 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 272.591 SH | 19. August 2026 | Täglich |
FATE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 18 Analysten
KAUF
Median-Ziel
$7.00
+201,7%
5 27,8%
Starker Kauf
6 33,3%
Kauf
7 38,9%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
9 Analysten · 2026-10-01Mittelwert-Ziel $5.74 +147,6%
Jetzt
Aktueller Preis $2.32
Tief$2.20
Mittelwert$5.74
Hoch$8.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| RCKT | · | · | · | · | · | · |
| ZSQR | · | · | · | · | · | · |
| IPSC | $87M | -7.1 | 1556.8% | -8.8% | -5.2% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| SABS | · | · | · | · | · | · |
| IKT | $270M | -4.2 | 111.0% | -1299.0% | -38.2% | · |
| TLSI | · | · | · | · | · | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026